Obinutuzumab
Update Venetoclax in CLL
(Update) Acalabrutinib in CLL and MCL
Acalabrutinib
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
NCCN COVID-19 Resources Page
NCCN Guidelines for Patients
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL